Ignite Creation Date:
2024-05-06 @ 4:06 AM
Last Modification Date:
2024-10-26 @ 11:44 AM
Study NCT ID:
NCT02459743
Status:
UNKNOWN
Last Update Posted:
2015-06-08
First Post:
2015-02-25
Brief Title:
Molecular Disease Profile of Hematological Malignancies
Sponsor:
Organization:
University of Pavia
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
2 Years
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
We developed a protocol to couple high-throughput sample handling with the power of massively parallel sequencing to sequence all coding exons of a target list of candidate genes in the cancer cells ie peripheral blood granulocytes for myeloid malignancies and mononucleated cells or CD19 cells for limphoproliferative neoplasms and normal control cells ie T lymphocytes for myeloid malignancies and buccal cells swab for lymphoproliferative diseases from a large well-characterized prospective cohort of patients with hematological malignancies
Enrollment Count:
1000
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 30323 |
Who Masked List: